New research could allow health care providers to identify and treat patients at risk for rheumatoid arthritis before the ...

People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, ...

Researchers find drug could delay rheumatoid arthritis by years - Rheumatoid arthritis affects about 400,000 people aged 16 ...

Patients given a combination of Eli Lilly & Co.’s weight-loss shot Zepbound and arthritis drug Taltz saw a greater ...

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

Researchers can use blood markers like anti-cyclic citrullinated peptide antibodies to identify those who are at risk much ...

If your joints are extra achy at this time of year, you're in good company. Wintery and wet weather can trigger flare-ups for ...

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese patients with an autoimmune condition that causes joint pain more than Taltz did ...

Studies show exercise, braces, and water therapy can reduce pain and improve mobility for millions with knee arthritis.

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

Scientists at Stanford Medicine have discovered a treatment that can reverse cartilage loss in aging joints and even prevent arthritis after knee injuries. By blocking a protein linked to aging, the ...